The SARS-CoV-2 seroprevalence is the key factor for deconfinement in France.
J Infect
; 81(2): 318-356, 2020 Aug.
Article
em En
| MEDLINE
| ID: mdl-32360497
A new virus, SARS-CoV-2, has spread world-wide since December 2019, probably affecting millions of people and killing thousands. Failure to anticipate the spread of the virus now seriously threatens many health systems. We have designed a model for predicting the evolution of the SARS-CoV-2 epidemic in France, which is based on seroprevalence and makes it possible to anticipate the deconfinement strategy.
Palavras-chave
Texto completo:
1
Bases de dados:
MEDLINE
Assunto principal:
Pneumonia Viral
/
Controle de Infecções
/
Infecções por Coronavirus
/
Pandemias
/
Betacoronavirus
Tipo de estudo:
Prognostic_studies
/
Risk_factors_studies
Limite:
Humans
País/Região como assunto:
Europa
Idioma:
En
Revista:
J Infect
Ano de publicação:
2020
Tipo de documento:
Article